Cargando…
Sulfamethoxazole-Trimethoprim (Cotrimoxazole) for Skin and Soft Tissue Infections Including Impetigo, Cellulitis, and Abscess
Skin and soft tissue infections (SSTI) affect millions of people globally, which represents a significant burden on ambulatory care and hospital settings. The role of sulfamethoxazole-trimethoprim (SXT) in SSTI treatment, particularly when group A Streptococcus (GAS) is involved, is controversial. W...
Autores principales: | Bowen, Asha C, Carapetis, Jonathan R, Currie, Bart J, Fowler, Vance, Chambers, Henry F, Tong, Steven Y C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730933/ https://www.ncbi.nlm.nih.gov/pubmed/29255730 http://dx.doi.org/10.1093/ofid/ofx232 |
Ejemplares similares
-
Psychosis resulting from trimethoprim-sulfamethoxazole treatment for preseptal cellulitis
por: Iqbal, Kashif M., et al.
Publicado: (2020) -
Efficacy of cotrimoxazole (Sulfamethoxazole-Trimethoprim) as a salvage therapy for the treatment of bone and joint infections (BJIs)
por: Deconinck, Laurene, et al.
Publicado: (2019) -
The Global Epidemiology of Impetigo: A Systematic Review of the Population Prevalence of Impetigo and Pyoderma
por: Bowen, Asha C., et al.
Publicado: (2015) -
Sulfamethoxazole-Trimethoprim and Hyperkalemia in an Infant
por: Hudzik, Samantha A., et al.
Publicado: (2020) -
Trimethoprim+Sulfamethoxazole Reduces Rates of Melioidosis in High-Risk Hemodialysis Patients
por: Majoni, Sandawana William, et al.
Publicado: (2017)